Adare Pharma Solutions Initiates Expansion of Pessano Facility in Italy
Adare Pharma Solutions, a global contract development and manufacturing organization (CDMO) focused on oral dosage forms, completed its divestiture of its Adare Biome business unit, a pioneer in the development and manufacturing of postbiotics, to dsm-firmenich, innovators in nutrition, health, and beauty. The transaction represents an enterprise value of €275 million.
DSM Acquires Adare Biome for €275 million
HILLSBOROUGH, N.J., March 21, 2023 /PRNewswire/ -- Adare Pharma Solutions, a leading contract development and manufacturing organization, today announced it has selected Vantage Solutions to lead a major upgrade of their pharmaceutical packaging capabilities.
Veeva Systems announced that Adare Pharma Solutions, a contract development and manufacturing organization (CDMO) with expertise in oral dosage forms, selected Veeva Vault Quality Suite to harmonize quality systems across the organization. By replacing legacy systems with modern connected applications, Adare can streamline quality processes, work more effectively with partners and suppliers, and deliver greater visibility into operations to customers.
Pharma Supply Chain People Moves
Tethis appoints Holger Neecke as the company`s Chief Executive Officer
DUBLIN, July 27, 2020 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH), a diversified biopharmaceutical company primarily focused on the discovery, development and commercialization of organ-selective medicines, will report its second quarter 2020 financial results and provide a business update after market close on Thursday, August 6, 2020. An accompanying conference call and simultaneous webcast will be hosted at 5:00 p.m. ET (2:00 p.m. PT/9:00 p.m. GMT) that day.
Adare Pharma Solutions: Integrated End-To-End CDMO